Intoplicine

Modify Date: 2024-01-08 16:33:10

Intoplicine Structure
Intoplicine structure
Common Name Intoplicine
CAS Number 125974-72-3 Molecular Weight 348.44100
Density 1.286g/cm3 Boiling Point 635.5ºC at 760mmHg
Molecular Formula C21H24N4O Melting Point N/A
MSDS N/A Flash Point 338.2ºC

 Use of Intoplicine


Intoplicine is a DNA topoisomerase I and II inhibitor.

 Names

Name Intoplicine
Synonym More Synonyms

 Intoplicine Biological Activity

Description Intoplicine is a DNA topoisomerase I and II inhibitor.
Related Catalog
Target

Topoisomerase I

Topoisomerase II

In Vitro Activity of Intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitro. Intoplicine (RP60475) is the most active analogue evaluated in the 7H-benzo[e]-pyrido-[4,3-b]-indole series of antineoplastic compounds. Intoplicine exerts its activity through inhibition of DNA topoisomerase I and II[1]. Intoplicine is found to unwind DNA and to inhibit purified calf thymus topoisomerase II via a stabilization of the ternary cleavable complex[2].
Kinase Assay The assay is performed with various concentrations of calf thymus Topo II (20 to 0.1 decatenation units) in a 20 μL final reaction volume containing 0.25 μg of supercoiled pBR322 DNA, 20 mM Tris HC1 (pH 7.5), 60 mM KCl, 10 mM MgCl2, 30 μg /mL bovine serum albumin, 0.5 mM EDTA, 0.5 mM Dithiothreitol, and 1 μM Intoplicine or water. The final nucleotide concentration is 20.8 μM.The reaction is assembled in ice and the reaction mixture is then incubated at 37°C for 5 min. Then sample is mixed at room temperature with 20 μL of preaggregated silver hydrosol and immediately analyzed by SERS. Control experiments consisting of measurement of the SERS spectra of buffer alone, Topo II alone, Intoplicine alone (1μM), DNA alone, Topo II+Intoplicine, and DNA+Intoplicine are performed under the same conditions, except that distilled water is used to adjust the reaction volume to 20μL[2].
Cell Assay The K562 human erythroleukemia cell line is established from a patient with chronic myelogenous leukemia. Cells are in the exponential growth phase at 5-8×105 in RPMI 1640 (GIBCO) supplemented with 10% fetal calf serum (Seromed) and 2 mM L-glutamine. Cell growth and viability are determined by phase contrast microscopy and by using the trypan blue test. Cells (2×106) are incubated with 1 μM Intoplicine for 1 h at 37°C, washed twice with PBS by centrifugation (200× g at 4°C) and resuspended in 200 μL PBS[2].
References

[1]. Eckardt JR, et al. Activity of Intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitro. J Natl Cancer Inst. 1994 Jan 5;86(1):30-3.

[2]. Morjani H, et al. Molecular and cellular interactions between Intoplicine, DNA, and topoisomerase II studied by surface-enhanced Raman scattering spectroscopy. Cancer Res. 1993 Oct 15;53(20):4784-90.

 Chemical & Physical Properties

Density 1.286g/cm3
Boiling Point 635.5ºC at 760mmHg
Molecular Formula C21H24N4O
Molecular Weight 348.44100
Flash Point 338.2ºC
Exact Mass 348.19500
PSA 64.18000
LogP 4.31990
Vapour Pressure 9.55E-17mmHg at 25°C
Index of Refraction 1.755
Storage condition 2-8℃

 Precursor & DownStream

Precursor  1

DownStream  0

 Synonyms

11-((3-(Dimethylamino)propyl)amino)-8-methyl-7H-benzo(e)pyrido(4,3-b)indol-3-ol
UNII-FB2CIN6HMI
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Intoplicine suppliers


Price: $1860/1mg

Reference only. check more Intoplicine price